ITMI921601A1 - Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci. - Google Patents

Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.

Info

Publication number
ITMI921601A1
ITMI921601A1 IT001601A ITMI921601A ITMI921601A1 IT MI921601 A1 ITMI921601 A1 IT MI921601A1 IT 001601 A IT001601 A IT 001601A IT MI921601 A ITMI921601 A IT MI921601A IT MI921601 A1 ITMI921601 A1 IT MI921601A1
Authority
IT
Italy
Prior art keywords
derivatives
pct
homo
bile acids
absorption promoters
Prior art date
Application number
IT001601A
Other languages
English (en)
Inventor
Giancarlo Ceschel
Aldo Roda
Enrico Roda
Celestino Ronchi
Original Assignee
Monteres S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monteres S R L filed Critical Monteres S R L
Publication of ITMI921601A0 publication Critical patent/ITMI921601A0/it
Priority to ITMI921601A priority Critical patent/IT1255449B/it
Priority to ES93912975T priority patent/ES2114056T3/es
Priority to AT93912975T priority patent/ATE161731T1/de
Priority to US08/360,833 priority patent/US5656277A/en
Priority to DE69316217T priority patent/DE69316217T2/de
Priority to EP93912975A priority patent/EP0652773B1/en
Priority to PCT/EP1993/001508 priority patent/WO1994000155A1/en
Priority to JP6501998A priority patent/JPH07508013A/ja
Priority to DK93912975T priority patent/DK0652773T3/da
Publication of ITMI921601A1 publication Critical patent/ITMI921601A1/it
Application granted granted Critical
Publication of IT1255449B publication Critical patent/IT1255449B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
ITMI921601A 1992-06-30 1992-06-30 Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci. IT1255449B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI921601A IT1255449B (it) 1992-06-30 1992-06-30 Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
DE69316217T DE69316217T2 (de) 1992-06-30 1993-06-15 Anwendung von nor- und homo-gallensäurederivaten als absorptienförderer für arzneimittel
AT93912975T ATE161731T1 (de) 1992-06-30 1993-06-15 Anwendung von nor- und homo-gallensäurederivaten als absorptienförderer für arzneimittel
US08/360,833 US5656277A (en) 1992-06-30 1993-06-15 Nor- and homo- bile acids derivatives as absorption enhancers for medicaments
ES93912975T ES2114056T3 (es) 1992-06-30 1993-06-15 Uso de derivados nor y homo de acidos biliares como potenciadores de absorcion para medicamentos.
EP93912975A EP0652773B1 (en) 1992-06-30 1993-06-15 The use of nor- and homo- bile acids derivatives as absorption enhancers for medicaments
PCT/EP1993/001508 WO1994000155A1 (en) 1992-06-30 1993-06-15 The use of nor- and homo- bile acids derivatives as absorption enhancers for medicaments
JP6501998A JPH07508013A (ja) 1992-06-30 1993-06-15 医薬物用吸収促進剤としてのノルおよびホモ胆汁酸誘導体の使用
DK93912975T DK0652773T3 (da) 1992-06-30 1993-06-15 Anvendelse af nor- og homo-galdesyrederivater somabsorptionsfremmende bestanddele i lægemidler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921601A IT1255449B (it) 1992-06-30 1992-06-30 Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.

Publications (3)

Publication Number Publication Date
ITMI921601A0 ITMI921601A0 (it) 1992-06-30
ITMI921601A1 true ITMI921601A1 (it) 1993-12-30
IT1255449B IT1255449B (it) 1995-10-31

Family

ID=11363597

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921601A IT1255449B (it) 1992-06-30 1992-06-30 Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.

Country Status (9)

Country Link
US (1) US5656277A (it)
EP (1) EP0652773B1 (it)
JP (1) JPH07508013A (it)
AT (1) ATE161731T1 (it)
DE (1) DE69316217T2 (it)
DK (1) DK0652773T3 (it)
ES (1) ES2114056T3 (it)
IT (1) IT1255449B (it)
WO (1) WO1994000155A1 (it)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821970A1 (en) * 1996-08-02 1998-02-04 Edward Henri Charles Verhaeren Carrier composition for influencing the tight junction permeability
CA2294988C (en) 1997-07-01 2015-11-24 Isis Pharmaceuticals Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
WO2000019978A2 (en) * 1998-10-05 2000-04-13 The Penn State Research Foundation Compositions and methods for enhancing receptor-mediated cellular internalization
US6451286B1 (en) 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US6375975B1 (en) 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US7087215B2 (en) * 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US6982281B1 (en) * 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US20030118547A1 (en) * 2000-01-27 2003-06-26 Vandenberg Grant William Composition for intestinal delivery
JP4452970B2 (ja) * 2002-03-27 2010-04-21 日本臓器製薬株式会社 ジクロフェナクナトリウム経口製剤
AU2005323437B2 (en) 2004-04-30 2011-10-06 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising a C5-modified pyrimidine
HUE030010T2 (en) 2005-05-12 2017-04-28 Medizinische Universität Graz 24-norUDCA for the treatment of autoimmune hepatitis
US20100311708A1 (en) * 2007-07-25 2010-12-09 Tarek Moustafa Use of nor-bile acids in the treatment of arteriosclerosis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
SG11201703717SA (en) 2014-11-06 2017-06-29 Enanta Pharm Inc Bile acid analogs an fxr/tgr5 agonists and methods of use thereof
AU2015353473A1 (en) 2014-11-26 2017-06-08 Enanta Pharmaceuticals, Inc. Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
WO2016086115A1 (en) 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
US10208081B2 (en) 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
SG11201706089RA (en) 2015-02-11 2017-09-28 Enanta Pharm Inc Bile acid analogs as fxr/tgr5 agonists and methods of use thereof
MY192135A (en) 2015-03-31 2022-07-29 Enanta Pharm Inc Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
WO2017147174A1 (en) 2016-02-23 2017-08-31 Enanta Pharmaceuticals, Inc. Heteroaryl containing bile acid analogs as fxr/tgr5 agonists and methods of use thereof
US10323060B2 (en) 2016-02-23 2019-06-18 Enanta Pharmaceuticals, Inc. Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof
WO2017147159A1 (en) 2016-02-23 2017-08-31 Enanta Pharmaceuticals, Inc. Deuterated bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. ORAL TESTOSTERONE UNDECANOATE THERAPY
ES2918698T3 (es) 2016-11-29 2022-07-19 Enanta Pharm Inc Proceso para la preparación de derivados del ácido biliar de las sulfonilureas
WO2018152171A1 (en) 2017-02-14 2018-08-23 Enanta Pharmaceuticals, Inc. Bile acid derivatives as fxr agonists and methods of use thereof
US10676500B2 (en) 2017-04-07 2020-06-09 Enanta Pharmaceuticals, Inc. Process for preparation of sulfonyl carbamate bile acid derivatives
GB201911821D0 (en) 2019-08-16 2019-10-02 Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy And Undivid Compounds for use in the treatment of liver disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
IT1212835B (it) * 1983-08-18 1989-11-30 Lehner Ag Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Also Published As

Publication number Publication date
EP0652773B1 (en) 1998-01-07
JPH07508013A (ja) 1995-09-07
DE69316217T2 (de) 1998-08-20
WO1994000155A1 (en) 1994-01-06
ES2114056T3 (es) 1998-05-16
DE69316217D1 (de) 1998-02-12
EP0652773A1 (en) 1995-05-17
IT1255449B (it) 1995-10-31
DK0652773T3 (da) 1998-09-07
ITMI921601A0 (it) 1992-06-30
US5656277A (en) 1997-08-12
ATE161731T1 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
ITMI921601A1 (it) Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
TR199902626T2 (xx) Enflamasyon tedavisi i�in ikameli benzopiran t�revleri.
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
DE69530081T2 (de) Gastrin- und cck-antagonisten
ITRM920919A1 (it) Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
SE9101709D0 (sv) Lipidderivat som diagnostikum eller kontrastmedel
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
ATE297203T1 (de) Antithrombotische mitteln
ES2114931T3 (es) Nuevos esteres esteroidales.
ES2193154T3 (es) Procedimiento para la preparacion de 9-desoxotaxanos.
FI954898A0 (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
ES2177656T3 (es) Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis.
KR950700234A (ko) β-페닐이소세린 및 그외 동족체를 제조하는 방법(Method for preparing β-phenylisoserine and analogues thereof)
DK0649405T3 (da) 22-en-25-oxa-derivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt anvendelse af sådanne præparater som lægemidler.
DK0609336T3 (da) Anvendelse af prostacyclin-derivater til forebyggelse eller behandling af lidelser i mikrocirkulationssystemet ved administ
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
FI950209A0 (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
AU1459192A (en) Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
ES2134971T3 (es) Derivado de acido octahidro-2-naftaleno-carboxilico, su produccion y uso.
SE9301831D0 (sv) Pharmaceutical compositions
ES2098119T3 (es) Nuevas triazoloquinazolinas, su obtencion y empleo.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960627